Premium
Human parvovirus B19 infection in pregnancy: should screening be offered to the low‐risk population?
Author(s) -
Fean Wong Shell,
Yee Chan Fung,
Cincotta Robert B,
Tilse Martin
Publication year - 2002
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.0004-8666.2002.00347.x
Subject(s) - parvovirus , pregnancy , asymptomatic , medicine , obstetrics , fetus , population , fetal death , virus , immunology , surgery , biology , environmental health , genetics
Human parvovirus B19 infection during pregnancy can result in fetal hydrops and death. Intra‐uterine transfusion in hydropic fetuses affected by the virus can reduce perinatal deaths. Up to 33% of women with this infection are asymptomatic. In view of the significant adverse outcomes, the role of routine screening among low‐risk pregnant women is discussed.